Answer
Tapentadol is not recommended in patients with severe renal impairment because it has not been studied in controlled efficacy trials in this population.
Sources for this answer
- Tapentadol Krka 150 mg prolonged-release tabletsKrka UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked